Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 20,376 shares at $100.34 ($2.0M) on 2019-11-01, disclosed to the SEC on 2019-11-05.
Open-market sale of $2.0M NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.34 | 10,188 | $1.0M | 50.0% |
| 2 | $100.34 | 10,188 | $1.0M | 50.0% |
| Total | $100.34 avg | 20,376 | $2.0M | 100% |
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |